A potential role of odorant receptor agonists and antagonists in the treatment of infertility and contraception.
In 1992, the identification of odorant receptor expression in mammalian testicular tissue prepared the ground for an ongoing debate about a potential role for these chemoreceptors in significant sperm behaviors, in particular chemotaxis. The identification of hOR17-4, a human testicular odorant receptor that mediates sperm chemotaxis in various bioassays, revealed the first potential key player in this reproductively relevant scenario. Detailed knowledge of the receptor's molecular receptive field, the discovery of a potent receptor antagonist, as well as specific insight into the receptor-linked signaling cascade(s), could establish a basis for pioneering future applications in fertility treatment and/or contraception.
Spehr
Marc
M
Department of Anatomy and Neurobiology, University of Maryland School of Medicine, 20 Penn Street, Baltimore, MD 21201, USA.
Hatt
Hanns
H
D003267:Contraception / Q000379:methods* / Q000639:trends*; D006801:Humans; D007248:Infertility, Male / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D008297:Male; D018035:Receptors, Odorant / Q000819:agonists / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D029589:Seminal Plasma Proteins / Q000819:agonists / Q000037:antagonists & inhibitors / Q000494:pharmacology*
C473192:OR1D2 protein, human; D018035:Receptors, Odorant; D029589:Seminal Plasma Proteins